Biomarkers for TBI Diagnosis and Prognosis

Type: diagnostic

Status: FDA Approved

Developer: Banyan Biomarkers, Inc.

Breakthrough Summary

No summary available.

Mechanism of Action

Details pending.

Year: 2026